A single-arm, open-label, long-term efficacy and safety study of subcutaneous (SC) romiplostim in children with immune thrombocytopenia (ITP)

The requested reference [239a29fd76ca809bf965b3d792c085885bdcba84] no longer exists in our database. It has been replaced by the current reference: [a4dd36e27fd9b54c47efce534c268531752111d2]

Authors
Category Primary study
JournalBlood
Year 2017
This article has no abstract
Epistemonikos ID: 19c5baee8b4c197938ef56b2abacfff6afd7b4e5
First added on: Feb 08, 2025